开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09939 开拓药业-B

已收盘 07-15 16:08:26

2.180

+0.140

+6.86%

最高2.280	最低1.980	成交量1,390万
今开2.000	昨收2.040	日振幅14.71%
总市值9.76亿	流通市值9.76亿	总股本4.47亿
成交额3,013万	换手率3.11%	流通股本4.47亿
市净率3.04	ROE-41.29%	每股收益-0.39
52周最高2.280	52周最低0.790	市盈率-5.53
股息0.00	股息收益率0.00	ROA-13.17%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":2.18,"timestamp":1752566906390,"preClose":2.04,"halted":0,"volume":13900500,"delay":0,"floatShares":447499600,"shares":447499600,"eps":-0.3939022881567482,"marketStatus":"已收盘","change":0.14,"latestTime":"07-15 16:08:26","open":2,"high":2.28,"low":1.98,"amount":30130370,"amplitude":0.147059,"askPrice":2.19,"askSize":178000,"bidPrice":2.18,"bidSize":65500,"shortable":0,"etf":0,"ttmEps":-0.3939022881567482,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752629400000},"marketStatusCode":5,"adr":0,"listingDate":1590076800000,"exchange":"SEHK","adjPreClose":2.04,"openAndCloseTimeList":[[1752543000000,1752552000000],[1752555600000,1752566400000]],"volumeRatio":2.082673,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2551916282","title":"本土传统药企出手！正大天晴母公司拟以5亿美元并购礼新医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2551916282","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551916282?lang=zh_cn&edition=full","pubTime":"2025-07-15 20:14","pubTimestamp":1752581656,"startTime":"0","endTime":"0","summary":"7月15日晚间，正大天晴母公司中国生物制药宣布，将以约5亿美元的净代价100%收购礼新医药科技（上海）有限公司。收购完成后，礼新医药将成为中国生物制药全资子公司。作为一家中国本土传统药企，近年来，中国生物制药已在加大力度向创新药企转型。如2023年12月底，亘喜生物以12亿美元卖身阿斯利康，成为首家被跨国药企并购的中国创新药企。但相比跨国药企，中国本土传统药企出手进行大额并购较为少见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715201713a6ab30c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715201713a6ab30c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","BK1191","SBHMY","09939","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1521","BK1161","BK1589","BK1574"],"gpt_icon":0},{"id":"2551694921","title":"中国生物制药5亿美金收购礼新医药，国际化战略再提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2551694921","media":"医药魔方Info","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551694921?lang=zh_cn&edition=full","pubTime":"2025-07-15 18:57","pubTimestamp":1752577061,"startTime":"0","endTime":"0","summary":"7月15日盘后，中国生物制药公告，将以约5亿美元的总价收购上海礼新医药95.09%股权，加上此前参与礼新C轮融资时既已取得的4.91%股权，交易完成后，礼新医药将成为中国生物制药全资子公司。截至目前，礼新医药累计对外授权近40亿美元，折合人民币近300亿元。此次中国生物制药收购礼新可谓强强联合，有望进一步强化中国生物制药创新研发能力，扩充管线并加速其国际化进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715190116a44c3b92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715190116a44c3b92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE00BZ08YT58.USD","01177","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1191","BK1589","BK1574","BK1161","BK1521","09939"],"gpt_icon":0},{"id":"2551152521","title":"亚辉龙：公司属于医药制造业中的医疗仪器设备及器械制造行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2551152521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551152521?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:18","pubTimestamp":1752567514,"startTime":"0","endTime":"0","summary":"证券之星消息，亚辉龙07月15日在投资者关系平台上答复投资者关心的问题。根据中国证监会颁布的《上市公司行业分类指引》，公司所处行业属于医药制造业；根据《国民经济行业分类》，公司所处行业为医药制造业中的医疗仪器设备及器械制造行业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071500026701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","688575","BK0239","159938","BK1574","159891","BK1161","09939"],"gpt_icon":0},{"id":"2551169802","title":"开拓药业-B07月15日获主力加仓59.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551169802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551169802?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:16","pubTimestamp":1752567362,"startTime":"0","endTime":"0","summary":"07月15日, 开拓药业-B股价涨6.86%，报收2.18元，成交金额3013.0万元，换手率3.11%，振幅14.71%，量比2.08。开拓药业-B今日主力资金净流入59.2万元，上一交易日主力净流入584.0万元。该股近5个交易日上涨38.85%，主力资金累计净流入798.3万元；近20日主力资金累计净流入533.2万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715170012a6aababa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715170012a6aababa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2551166355","title":"华昊中天医药-B07月15日主力净流入17.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2551166355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551166355?lang=zh_cn&edition=full","pubTime":"2025-07-15 16:15","pubTimestamp":1752567333,"startTime":"0","endTime":"0","summary":"07月15日, 华昊中天医药-B股价涨2.42%，报收7.61元，成交金额157.0万元，换手率0.10%，振幅5.52%，量比0.43。华昊中天医药-B今日主力资金净流入17.9万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.28%，主力资金累计净流入6.8万元；近20日主力资金累计净流出294.5万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165056a44be666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715165056a44be666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563","BK1574","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2551590681","title":"医药巨头白云山，陷入业绩之“困”","url":"https://stock-news.laohu8.com/highlight/detail?id=2551590681","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551590681?lang=zh_cn&edition=full","pubTime":"2025-07-15 15:10","pubTimestamp":1752563416,"startTime":"0","endTime":"0","summary":"在这些被调出的医药生物股中，就有中药巨头白云山的身影。近年来，白云山业绩“天花板”已经隐现。药企巨头之“困”资料显示，白云山制药厂成立于1973年，当时广州白云山农场买下一个停产歇业的中草药车间，成立了“白云山农场制药车间”，这就是白云山的前身。拉长周期来看，这也是在2020年之后白云山再度遭遇业绩“双降”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1752545262618925226","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1574","BK1606","BK1515","BK1191","BK1197","00874","BK1161","BK1521","09939"],"gpt_icon":0},{"id":"2551155538","title":"同源康医药-B盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551155538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551155538?lang=zh_cn&edition=full","pubTime":"2025-07-15 13:01","pubTimestamp":1752555709,"startTime":"0","endTime":"0","summary":"2025年07月15日下午盘13时01分，同源康医药-B股票出现异动，股价大幅下跌5.12%。截至发稿，该股报18.900港元/股，成交量106.15万股，换手率0.29%，振幅5.52%。同源康医药-B股票所在的生物技术行业中，整体涨幅为1.52%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715130149a6aa4174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715130149a6aa4174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","02410","09939"],"gpt_icon":0},{"id":"2551813904","title":"达仁堂：中新医药股权增资致现金流量表与资产负债表差异","url":"https://stock-news.laohu8.com/highlight/detail?id=2551813904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551813904?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:39","pubTimestamp":1752485965,"startTime":"0","endTime":"0","summary":"达仁堂回复：2024年现金流量表中取得与偿还借款差额主要为天津中新医药有限公司年内产生。但2024年末，已完成中新医药的全部股权增资津药太平医药有限公司，交易完成后津药太平医药为联营公司，中新医药不再纳入合并范围，故2024年末资产负债表不再包含中新医药对应的资产负债项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400025659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1574","159938","BK0028","600329","BK1515","BK1161","BK0060","BK0239","BK0164","09939"],"gpt_icon":0},{"id":"2551186246","title":"每日卖空追踪 | 同源康医药-B 07月14日卖空量成交4000股，卖空比例为0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551186246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551186246?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:30","pubTimestamp":1752481828,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间07月14日，涨0.5%，卖空量成交4000股%，较上一交易日减少33.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714172554a4498f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714172554a4498f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1574","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2551790519","title":"7月14日爱迪特涨6.91%，银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551790519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551790519?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:22","pubTimestamp":1752481354,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日爱迪特涨6.91%创60日新高，收盘报43.65元，换手率6.11%，成交量4.4万手，成交额1.87亿元。重仓爱迪特的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为4.93亿元，最新净值0.5706，较上一交易日上涨0.53%，近一年上涨26.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400021758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159938","BK0251","BK1515","301580","09939","BK1161"],"gpt_icon":0},{"id":"2551726429","title":"【券商聚焦】平安证券(香港)：港股股权融资规模同比大增350% 建议关注科技医药消费等板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2551726429","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551726429?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:29","pubTimestamp":1752474580,"startTime":"0","endTime":"0","summary":"金吾财讯 | 平安证券 指出，2025年以来，港股市场无论是IPO还是再融资都极为火热。Wind数据显示，2025年以来，港股市场股权融资规模已逼近3000亿港元，达到2879.82亿港元，同比大增350.56%。总体来看，港股市场今年无论是IPO规模还是再融资规模都有爆发式的增长，而IPO方面的表现更为抢眼。港股上半年共完成了42宗首次公开招股发行，合共集资额超过1070亿港元，已较去年全年多约22%，暂列全球第一。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962177","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4614","YANG","159938","BK1574","HSTECH","161027","HSCEI","BK1161","09939"],"gpt_icon":0},{"id":"2551973369","title":"开拓药业-B盘中异动 快速上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551973369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551973369?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:45","pubTimestamp":1752461107,"startTime":"0","endTime":"0","summary":"2025年07月14日早盘10时45分，开拓药业-B股票出现波动，股价大幅上涨5.52%。截至发稿，该股报1.910港元/股，成交量176.7万股，换手率0.39%，振幅6.08%。开拓药业-B股票所在的药品行业中，整体涨幅为2.01%。其相关个股中，天大药业、恒瑞医药、山东新华制药股份涨幅较大，振幅较大的相关个股有天大药业、恒瑞医药、丽珠医药，振幅分别为10.00%、9.42%、8.94%。开拓药业-B公司简介：开拓药业有限公司是临床阶段新药开发商。该公司在皮科领域有两款核心药物KX-826及GT20029。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104508a448c6b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714104508a448c6b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2551992601","title":"【兴业证券：券商引领指数新高后的市场特征】券商突破后20个交易日内，以军工、医药、TMT、美护为代表的成长行业和化工、机械、新能源等α机会较多的行业领涨概率较大，本质上还是2010年我国进入发展新常态后，总量经济难以持续超预期，风险偏好提升后，市场倾向于到偏成长的行业找寻结构性机会。","url":"https://stock-news.laohu8.com/highlight/detail?id=2551992601","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551992601?lang=zh_cn&edition=full","pubTime":"2025-07-14 07:53","pubTimestamp":1752450816,"startTime":"0","endTime":"0","summary":"券商突破后20个交易日内，以军工、医药、TMT、美护为代表的成长行业和化工、机械、新能源等α机会较多的行业领涨概率较大，本质上还是2010年我国进入发展新常态后，总量经济难以持续超预期，风险偏好提升后，市场倾向于到偏成长的行业找寻结构性机会。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/14075351664486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["399941","BK0012","BK1161","160640","BK0028","BK1515","09939","BK0188","159875","159938","BK0183","BK0276","161024","601377","BK1574","000941.SH"],"gpt_icon":0},{"id":"2551942510","title":"劲方医药获IPO备案：年亏损6.8亿 华盖与百度风投是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2551942510","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551942510?lang=zh_cn&edition=full","pubTime":"2025-07-13 22:08","pubTimestamp":1752415693,"startTime":"0","endTime":"0","summary":"劲方医药科技（上海）股份有限公司（简称：“劲方医药”）日前获IPO备案，拿到了上市的钥匙。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250713/6388804119590308398961714.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250713/6388804119590308398961714.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n30555/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK4602","BK4612","BK4535","BK4531","LU1023057109.AUD","09939","BK4548","BK4504","LU1115378108.SGD","LU0359201612.USD","BK4587","BK4579","IE00B0JY6N72.USD","BK4526","BK4588","LU0640798160.USD","BK1574","LU0173614495.USD","BK4552","LU0287142896.SGD","BK4574","BK4585","BK4614","BK4543","BK1515","BK4077","BK1161","BK4514","LU0359202008.SGD"],"gpt_icon":1},{"id":"2551912560","title":"每周股票复盘：英特集团（000411）收购华通医药，强化浙江市场布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2551912560","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551912560?lang=zh_cn&edition=full","pubTime":"2025-07-13 07:44","pubTimestamp":1752363848,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘，英特集团报收于10.95元，较上周的10.81元上涨1.3%。本周，英特集团7月8日盘中最高价报10.96元。问：（三）公司收购华通医药的目的答：英特药业以 36,910.00 万元的价格成功竞得华通医药 100%股权，并已与转让方签署了相关股权交易合同。本次交易符合公司战略规划及业务发展需要，有助于提升公司医药批发及零售业务在浙江市场的占有率，增强对上游供应商的议价能力和终端消费者的影响力，推动公司高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0102","BK1515","BK0097","09939","000411","159938","BK1574","BK1161"],"gpt_icon":1},{"id":"2550999050","title":"浙江幸星装备取得医药用易清理精馏釜专利，能对罐体内壁进行整体清洗不再有残液残留","url":"https://stock-news.laohu8.com/highlight/detail?id=2550999050","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550999050?lang=zh_cn&edition=full","pubTime":"2025-07-12 19:41","pubTimestamp":1752320518,"startTime":"0","endTime":"0","summary":"金融界2025年7月12日消息，国家知识产权局信息显示，浙江幸星装备有限公司取得一项名为“一种医药用易清理精馏釜”的专利，授权公告号CN223082282U，申请日期为2024年08月。天眼查资料显示，浙江幸星装备有限公司，成立于2020年，位于湖州市，是一家以从事专用设备制造业为主的企业。通过天眼查大数据分析，浙江幸星装备有限公司参与招投标项目4次，专利信息6条，此外企业还拥有行政许可6个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/12194151658234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","09939","159938","BK1161","BK1515"],"gpt_icon":0},{"id":"2550971879","title":"一周大涨超38%！这只医药股，不到半个月接待了四批机构调研！","url":"https://stock-news.laohu8.com/highlight/detail?id=2550971879","media":"e公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550971879?lang=zh_cn&edition=full","pubTime":"2025-07-12 17:01","pubTimestamp":1752310860,"startTime":"0","endTime":"0","summary":"本周，市场情绪进一步升温，A股三大指数全线走高。上证指数全周上涨1.09%，站稳3500点关口；深证成指全周涨1.78%，创业板指涨2.36%。根据Wind统计，本周共有160家上市公司披露机构调研纪要，约百只调研股实现正收益。　　联环药业7月以来已经举行了四次机构调研活动，7月累计涨幅已经达到49%，创新药概念近期的热度由此可见一斑。　　万泰生物在本周接待19家机构调研。中亦科技在接待调研中应询回应称，尚未涉及稳定币相关业务。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-07-12/doc-inffffqf1566727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","09939","159938","BK1515"],"gpt_icon":0},{"id":"2550962615","title":"【ETF动向】7月11日平安医药及医疗器械创新ETF基金涨1.42%，份额增加1.61亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2550962615","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550962615?lang=zh_cn&edition=full","pubTime":"2025-07-12 06:31","pubTimestamp":1752273081,"startTime":"0","endTime":"0","summary":"证券之星消息，7月11日，平安医药及医疗器械创新ETF基金（516820）涨1.42%，成交额1.59亿元。当日份额增加了1.61亿份，最新份额为44.42亿份，近20个交易日份额增加4.03亿份。当日资金净流入8034.56万元（资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的），最新资产净值计算值为15.91亿元。平安医药及医疗器械创新ETF基金跟踪标的为中证医药及医疗器械创新指数，成立（2021-06-09）以来超额回报为1.65%，近一个月超额回报为0.41%，管理人为平安基金公司，基金经理为翁欣 白圭尧。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071200005363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","159987","BK1222","BK1515","09996","BK1161","159938","BK1100","BK1583","159883","BK1574","09997"],"gpt_icon":0},{"id":"2550957803","title":"美股异动 | 医药板块走低 诺和诺德(NVO.US)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550957803","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550957803?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:21","pubTimestamp":1752247279,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，美股医药板块走低，未能延续本周涨势。截至发稿，诺和诺德(NVO.US)跌超3%，Moderna(MRNA.US)跌超2.4%，礼来(LLY.US)跌超1%，辉瑞(PFE.US)跌近1%。消息面上，据报道，FDA可能会加快药物审评以降低美国药品价格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0eae99d4bb3c0558aa729c90596db1e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1093756325.SGD","LU1093756168.USD","159938","09939","IE00BKVL7J92.USD","BK4585","BK1161","BK4599","BK1515","BK1574","BK4532","NVO","BK4588","BK4007","IE00BZ1G4Q59.USD","LU0154236417.USD"],"gpt_icon":0},{"id":"2550930547","title":"先通医药赴港上市收证监会反馈意见：茅台金石入股价格是否合理？与保荐人中信证券关联关系是否影响独立性？","url":"https://stock-news.laohu8.com/highlight/detail?id=2550930547","media":"新浪港股-好仓工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550930547?lang=zh_cn&edition=full","pubTime":"2025-07-11 19:06","pubTimestamp":1752231960,"startTime":"0","endTime":"0","summary":"　　7月11日，先通国际收到证监会关于本次境外上市的备案反馈意见，具体反馈如下：。　　三、说明公司生产线是否实际投入使用及相关合规性情况。　　四、说明国有股东标识办理进展情况。　　五、说明本次拟参与 “全流通” 的股东所持股份是否存在被质押、冻结或其他权利瑕疵的情形。　　近期，先通国际计划赴港上市的消息引发了资本市场的广泛关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigc/ggxg/zjhfk/2025-07-11/doc-inffcarm9212594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1951186391.HKD","LU0067412154.USD","LU1439103000.SGD","LU2328871848.SGD","LU0577902298.EUR","LU1969619763.USD","SG9999002562.SGD","LU0084288322.USD","LU0456827905.SGD","LU1580142542.USD","600519","SG9999001903.USD","LU0651946864.USD","09939","159938","LU0370786039.SGD","06030","LU0516422952.EUR","LU0348814723.USD","LU1781817850.SGD","SG9999006597.SGD","LU1820825898.SGD","LU0823426480.USD","LU1226287792.SGD","BK1161","LU0328353924.USD","LU0359202008.SGD","LU0588546209.SGD","LU0359201612.USD","LU0577902538.SGD","LU0594300419.USD","BK1147","BK0015","LU0594300179.USD","LU1688375341.USD","LU0348825331.USD","LU1226287875.USD","LU0072913022.USD","LU0320764599.SGD","LU0880133367.SGD","600030","LU2399975544.HKD","LU0516422440.USD","LU0417516902.SGD","LU2097828714.EUR","LU1008478684.HKD","LU0181495838.USD","LU1152091168.USD","LU2289578879.USD","LU0405327494.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":0.283},{"period":"1month","weight":0.2143},{"period":"3month","weight":0.7586},{"period":"6month","weight":1.2667},{"period":"1year","weight":0.8889},{"period":"ytd","weight":1.1031}],"compareEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.013},{"period":"3month","weight":0.1275},{"period":"6month","weight":0.255},{"period":"1year","weight":0.3231},{"period":"ytd","weight":0.2065}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家临床阶段新药开发商，专注于研究癌症药物及其他雄激素受体（AR）相关疾病药物。该公司的主要在研药物是普克鲁胺。该药物正在中国进行转移性去势抵抗性前列腺癌（mCRPC）的III期临床试验。该公司处于临床阶段在研药物还包括一种II期小分子在研药物Pyrilutamide、一种II期单克隆抗体在研药物ALK-1、一种I期mTOR抑制剂Detorsertib、以及一种hedgehog信号转导途径抑制剂GT1708F。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.063412},{"month":2,"riseRate":0.8,"avgChangeRate":0.219909},{"month":3,"riseRate":0.4,"avgChangeRate":0.084454},{"month":4,"riseRate":0.6,"avgChangeRate":0.421119},{"month":5,"riseRate":0.6,"avgChangeRate":0.045244},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.066873},{"month":7,"riseRate":0.666667,"avgChangeRate":0.075373},{"month":8,"riseRate":0.2,"avgChangeRate":-0.059234},{"month":9,"riseRate":0.2,"avgChangeRate":-0.170155},{"month":10,"riseRate":0.2,"avgChangeRate":-0.081213},{"month":11,"riseRate":0.6,"avgChangeRate":0.071209},{"month":12,"riseRate":0.2,"avgChangeRate":-0.215118}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}